Physician profile
Gary Warburton
NPI 1962545947
$330,370.39
in general payments reported to CMS, 2019-2025
6 companies · $81K in 2025
The $81K reported for 2025 was more than what 99% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,307 · 2020: $169 · 2021: $54K · 2022: $74K · 2023: $48K · 2024: $71K · 2025: $81K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $168K · Travel and Lodging: $28K · Food and Beverage: $3,906 · Education: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $168,272.50 |
| Travel and Lodging | $28,415.48 |
| Food and Beverage | $3,905.93 |
| Education | $415.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $328,712.50 | 2019-2025 | Patient-Fitted Tmj Reconstructive Prosthesis System, Universal Neuro 3, Na |
| Nexus Cmf, LLC | $1,072.60 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $480.04 | 2019 | |
| Depuy Synthes Sales INC. | $56.61 | 2019 | |
| Geistlich Pharma, North America, INC. | $27.11 | 2019 | |
| Kls-Martin L.P. | $21.53 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Warburton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.